HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Götte Selected Research

Endothelin-1 (Endothelin 1)

9/2010ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
12/2007On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Götte Research Topics

Disease

66Neoplasms (Cancer)
04/2024 - 01/2006
48Breast Neoplasms (Breast Cancer)
03/2024 - 04/2005
16Inflammation (Inflammations)
04/2024 - 04/2002
14Endometriosis
03/2022 - 03/2013
11Neoplasm Metastasis (Metastasis)
03/2024 - 11/2006
11Carcinogenesis
12/2022 - 01/2007
10Triple Negative Breast Neoplasms
09/2023 - 01/2013
9Inflammatory Breast Neoplasms
01/2023 - 01/2017
8Carcinoma (Carcinomatosis)
01/2022 - 01/2006
6Ovarian Neoplasms (Ovarian Cancer)
06/2023 - 07/2021
5Hypersensitivity (Allergy)
01/2020 - 04/2009
4Wounds and Injuries (Trauma)
01/2021 - 10/2004
3Glioblastoma (Glioblastoma Multiforme)
04/2024 - 05/2020
3Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2023 - 07/2021
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2023 - 01/2007
3Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 10/2011
3Pathologic Processes
01/2021 - 11/2004
3Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
04/2008 - 02/2005
2Glioma (Gliomas)
04/2024 - 01/2021
2Necrosis
03/2022 - 01/2021
2Disease Progression
07/2021 - 11/2014
2Colonic Neoplasms (Colon Cancer)
01/2021 - 01/2020
2Cysts
10/2020 - 01/2013
2Brain Neoplasms (Brain Tumor)
05/2020 - 01/2019
2Colitis
01/2017 - 01/2010
1Fibrosis (Cirrhosis)
03/2024
1Leiomyoma (Uterine Fibroids)
01/2024
1Sarcoma (Soft Tissue Sarcoma)
01/2024

Drug/Important Bio-Agent (IBA)

31Syndecan-1 (Syndecan 1)IBA
11/2023 - 04/2002
19MicroRNAs (MicroRNA)IBA
04/2024 - 09/2012
18Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
06/2023 - 10/2004
14Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2014
13Proteoglycans (Proteoglycan)IBA
03/2023 - 01/2007
13Small Interfering RNA (siRNA)IBA
12/2022 - 09/2012
12Heparitin Sulfate (Heparan Sulfate)IBA
12/2022 - 04/2003
10Proteins (Proteins, Gene)FDA Link
04/2024 - 07/2014
10Messenger RNA (mRNA)IBA
12/2022 - 04/2005
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2022 - 10/2004
7EnzymesIBA
03/2024 - 11/2006
7CytokinesIBA
03/2023 - 04/2009
7Hyaluronic Acid (Hyaluronan)IBA
12/2022 - 11/2006
7ChemokinesIBA
05/2021 - 04/2002
6heparanaseIBA
03/2024 - 11/2006
6LigandsIBA
03/2024 - 09/2006
6DecorinIBA
03/2024 - 02/2005
6Estrogens (Estrogen)FDA Link
11/2022 - 07/2014
6IntegrinsIBA
11/2022 - 04/2002
6GlycosaminoglycansIBA
09/2020 - 11/2004
5SyndecansIBA
03/2024 - 04/2003
5RNA-Binding Proteins (RNA-Binding Protein)IBA
08/2023 - 03/2020
5Syndecan-4IBA
11/2022 - 07/2007
5Cadherins (E-Cadherin)IBA
10/2022 - 01/2007
5Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 07/2014
5Estrogen ReceptorsIBA
01/2022 - 06/2009
4Peptide Hydrolases (Proteases)FDA Link
05/2022 - 10/2004
4Hormones (Hormone)IBA
11/2021 - 01/2013
4Indicators and Reagents (Reagents)IBA
10/2021 - 09/2012
3BiglycanIBA
03/2024 - 08/2005
3ErbB Receptors (EGF Receptor)IBA
09/2023 - 08/2010
3Thromboplastin (Tissue Factor)IBA
02/2023 - 05/2021
3Phenobarbital (Luminal)FDA Link
01/2022 - 01/2018
3CollagenIBA
01/2021 - 07/2006
3Protein Isoforms (Isoforms)IBA
12/2017 - 02/2015
3Estradiol (Delestrogen)FDA LinkGeneric
12/2017 - 04/2005
3Endothelin A ReceptorIBA
09/2010 - 04/2005
3Endothelins (Endothelin)IBA
08/2010 - 04/2005
2LuciferasesIBA
01/2023 - 09/2012
2Zoledronic Acid (Zometa)FDA Link
11/2022 - 01/2021
2Trastuzumab (Herceptin)FDA Link
11/2022 - 08/2010
2Extracellular Matrix ProteinsIBA
11/2022 - 05/2022
2Syndecan-3IBA
05/2022 - 12/2009
2ResveratrolIBA
01/2022 - 01/2021
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2021 - 05/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 02/2015
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2019
2SulfotransferasesIBA
01/2021 - 01/2020
2Transforming Growth Factor beta (TGF-beta)IBA
10/2020 - 01/2019
2Estrogen Receptor betaIBA
12/2017 - 06/2009
2Estrogen Receptor alphaIBA
12/2017 - 06/2009
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2017 - 01/2010
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 05/2013
2Dextrans (Dextran)FDA Link
01/2017 - 01/2010
2OxazoloneIBA
12/2011 - 04/2009
2Fulvestrant (Faslodex)FDA Link
09/2010 - 06/2009
2Aromatase InhibitorsIBA
09/2010 - 06/2009
2Endothelin-1 (Endothelin 1)IBA
09/2010 - 12/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 08/2005
2xylosylprotein 4-beta-galactosyltransferaseIBA
04/2008 - 07/2006
1gag Gene Products (gag Protein)IBA
03/2024
1Heparin (Liquaemin)FDA LinkGeneric
03/2024
1OsteonectinIBA
03/2023
1Hyaluronan SynthasesIBA
12/2022
1Blood Proteins (Serum Proteins)IBA
11/2022

Therapy/Procedure

25Therapeutics
08/2023 - 12/2007
11Drug Therapy (Chemotherapy)
04/2024 - 01/2006
2Immunotherapy
04/2024 - 01/2020
2Neoadjuvant Therapy
07/2014 - 01/2006
1Precision Medicine
03/2024
1Radiotherapy
03/2023
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2023